Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Accurate tumor genetic profiling is crucial for personalized cancer treatment.
• Traditional methods often rely on larger surgical specimens, limiting early diagnostic potential.

Purpose of the Study:

• To assess the feasibility of obtaining representative gene expression profiles from clinical core biopsies.
• To evaluate core biopsies as a reliable source for microarray analysis in cancer research.

Main Methods:

• Performed 16-gauge needle core biopsies and excision biopsies on human xenografts (Ewing's sarcoma, neuroblastoma) in mice.
• Isolated RNA, amplified it using a modified Eberwine protocol, and analyzed via human cDNA microarray.
• Compared gene expression profiles from core biopsies (amplified RNA) with surgical specimens (non-amplified RNA).

Main Results:

• Gene expression profiles from core biopsies maintained integrity compared to surgical specimens, as shown by hierarchical clustering.
• Microarray analysis successfully differentiated Ewing's sarcoma from neuroblastoma using both core and excisional biopsy materials.
• Pooling core biopsies did not enhance concordance with excisional biopsy results.

Conclusions:

• Clinical core biopsies are a suitable and reliable source for determining tumor genetic profiles.
• This technique supports the potential for using minimally invasive biopsies in molecular diagnostics.
• Core biopsy gene expression profiling can aid in differentiating tumor types.